1. Arbuck SG, Strauss H, Rowinsky E, Christian M, Suffness M, Adams J, Oakes M, McGuire W, Reed E, Gibbs H (1993) A reassessment of cardiac toxicity associated with Taxol. J Nat Cancer Inst Monogr 15:117–130
2. Ashkenazi A (2008) Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov 7:1001–1012
3. Beretta GL, Gatti L, Perego P, Zaffaroni N (2013) Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug. Curr Med Chem 20:1541–1565
4. Brooks DJ, Srinivas NR, Alberts DS, Thomas T, Igwemzie LM, McKinney LM, Randolph J, Schacter L, Kaul S, Barbhaiya RH (1995) Phase I and pharmacokinetic study of etoposide phosphate. Anti-Cancer Drugs 6:637–644
5. Brooks TA, Minderman H, O’Loughlin KL, Pera P, Ojima I, Baer MR, Bernacki RJ (2003) Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Mol Cancer Ther 2:1195–1205